Novel Antibody-Drug Conjugate Demonstrates Durable Responses in Patients With Platinum-Resistant Ovarian Cancer

• by

• October 8, 2026

Three Targets, One CAR T Therapy

First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions in B-cell lymphoma

• October 19, 2026

• 4 min

Author Correction: Liquid biopsy for early detection of pancreatic ductal adenocarcinoma

• by Caiming Xu, Alessandro Mannucci, Haiyong Han, Ruben M. Munoz, Derek Cridebring, Sourat Darabi, Yuji Toiyama, Yoshinaga Okugawa, Gagandeep Singh, Mustafa Raoof, Joon Oh Park, James Lin, Gregory Idos, Michael J. Demeure, Erkut Borazanci, Douglas B. Evans, Susan Tsai, Eunsung Jun, Carlos Becerra, Scott A. Celinski, Laleh Melstrom, Vincent Chung, Guixin Zhang, Dong Shang, David L. Bartlett, Mitsuro Kanda, Song Cheol Kim, Valsamo Anagnostou, Giulia Martina Cavestro, John S. Bolton, Ali H. Zaidi, Daniel Von Hoff, Ajay Goel

• October 26, 2026

Engineering a New Generation of Cancer-Fighting Cells

USC researchers develop a scalable cell engineering platform that could overcome key manufacturing and therapeutic limitations of CAR-based immunotherapies

• October 28, 2026

• 3 min